Pfizer Inc.  

(Public, NYSE:PFE)   Watch this stock  
Find more results for PFIZER INC
30.71
-0.21 (-0.68%)
Real-time:   12:32PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 30.20 - 30.90
52 week 27.12 - 32.96
Open 30.90
Vol / Avg. 17.43M/30.06M
Mkt cap 196.35B
P/E 18.61
Div/yield 0.26/3.39
EPS 1.65
Shares 6.39B
Beta 0.64
Inst. own 72%
May 5, 2014
Q1 2014 Pfizer Earnings Conference Call - 10:00AM EDT - Add to calendar
May 5, 2014
Q1 2014 Pfizer Earnings Release - 9:30AM EDT - Add to calendar
Apr 24, 2014
Pfizer 2014 Annual Shareholder Meeting
Apr 6, 2014
Pfizer Conference Call to review Palbociclib Phase 2 PALOMA-1 Results at AACR Annual Meeting 2014 - Webcast
Mar 29, 2014
Pfizer at American College of Cardiology (ACC) 2014: 63rd Annual Scientific Session & Expo
Mar 10, 2014
Pfizer at EBD BIO-Europe Spring
Feb 25, 2014
Pfizer at Citi Global Healthcare Conference
Jan 28, 2014
Q4 2013 Pfizer Earnings Conference Call - Webcast
Jan 28, 2014
Q4 2013 Pfizer Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 19.41% 22.12%
Operating margin 21.50% 31.32%
EBITD margin - 45.80%
Return on average assets 5.94% 6.38%
Return on average equity 13.36% 14.45%
Employees 77,700 -
CDP Score - 91 B

Address

235 E 42ND ST
NEW YORK, NY 10017
United States - Map
+1-212-5732323 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company�s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. Primary Care operating segment includes revenues from human prescription pharmaceutical products primarily prescribed by primary-care physicians. In November 2012, the Company acquired NextWave Pharmaceuticals, Inc. On November 30, 2012, the Company completed the sale of its Nutrition business.

Officers and directors

Ian C. Read Chairman of the Board, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Frank A. D'Amelio Chief Financial Officer, Executive Vice President - Business Operations
Age: 56
Bio & Compensation  - Reuters
Albert Bourla Group President - Vaccines, Oncology and Consumer Healthcare Business
Bio & Compensation  - Reuters
Mikael Dolsten M.D., Ph.D. President - Worldwide Research and Development
Age: 54
Bio & Compensation  - Reuters
Susan Silbermann President and General Manager, Global Vaccines Business
Bio & Compensation  - Reuters
Douglas M. Lankler Executive Vice President, General Counsel
Age: 47
Bio & Compensation  - Reuters
Charles H. Hill III Executive Vice President - Worldwide Human Resources
Age: 57
Bio & Compensation  - Reuters
Freda C. Lewis-Hall M.D. Executive Vice President, Chief Medical Officer
Age: 58
Bio & Compensation  - Reuters
Anthony J. Maddaluna Executive Vice President; President, Pfizer Global Supply
Age: 60
Bio & Compensation  - Reuters
Laurie J. Olson Executive Vice President - Strategy, Portfolio and Commercial Operations
Age: 49
Bio & Compensation  - Reuters